These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 26971844)
1. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. Modlin IM; Bodei L; Kidd M Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumor biomarkers: current status and perspectives. Modlin IM; Oberg K; Taylor A; Drozdov I; Bodei L; Kidd M Neuroendocrinology; 2014; 100(4):265-77. PubMed ID: 25300695 [TBL] [Abstract][Full Text] [Related]
3. Chromogranin A: any relevance in neuroendocrine tumors? Kidd M; Bodei L; Modlin IM Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):28-37. PubMed ID: 26627724 [TBL] [Abstract][Full Text] [Related]
4. Consensus on biomarkers for neuroendocrine tumour disease. Oberg K; Modlin IM; De Herder W; Pavel M; Klimstra D; Frilling A; Metz DC; Heaney A; Kwekkeboom D; Strosberg J; Meyer T; Moss SF; Washington K; Wolin E; Liu E; Goldenring J Lancet Oncol; 2015 Sep; 16(9):e435-e446. PubMed ID: 26370353 [TBL] [Abstract][Full Text] [Related]
5. Blood mRNA Measurement (NETest) for Neuroendocrine Tumor Diagnosis of Image-Negative Liver Metastatic Disease. Malczewska A; Bodei L; Kidd M; Modlin IM J Clin Endocrinol Metab; 2019 Mar; 104(3):867-872. PubMed ID: 30358858 [TBL] [Abstract][Full Text] [Related]
6. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection. Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994 [TBL] [Abstract][Full Text] [Related]
7. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Oberg K; Krenning E; Sundin A; Bodei L; Kidd M; Tesselaar M; Ambrosini V; Baum RP; Kulke M; Pavel M; Cwikla J; Drozdov I; Falconi M; Fazio N; Frilling A; Jensen R; Koopmans K; Korse T; Kwekkeboom D; Maecke H; Paganelli G; Salazar R; Severi S; Strosberg J; Prasad V; Scarpa A; Grossman A; Walenkamp A; Cives M; Virgolini I; Kjaer A; Modlin IM Endocr Connect; 2016 Sep; 5(5):174-87. PubMed ID: 27582247 [TBL] [Abstract][Full Text] [Related]
8. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract. Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155 [TBL] [Abstract][Full Text] [Related]
9. An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis. Malczewska A; Kidd M; Matar S; Kos-Kudła B; Bodei L; Oberg K; Modlin IM Neuroendocrinology; 2020; 110(3-4):198-216. PubMed ID: 31266019 [TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience. Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553 [TBL] [Abstract][Full Text] [Related]
11. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms. Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665 [TBL] [Abstract][Full Text] [Related]
12. The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors. Malczewska A; Kos-Kudła B; Kidd M; Drozdov I; Bodei L; Matar S; Oberg K; Modlin IM Adv Med Sci; 2020 Mar; 65(1):18-29. PubMed ID: 31841822 [TBL] [Abstract][Full Text] [Related]
13. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171 [TBL] [Abstract][Full Text] [Related]
14. The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression. Filosso PL; Kidd M; Roffinella M; Lewczuk A; Chung KM; Kolasinska-Cwikla A; Cwikla J; Lowczak A; Doboszynska A; Malczewska A; Catalano M; Zunino V; Boita M; Arvat E; Cristofori R; Guerrera F; Oliaro A; Tesselaar M; Buikhuisen W; Kos-Kudla B; Papotti M; Bodei L; Drozdov I; Modlin I Eur J Cardiothorac Surg; 2018 Mar; 53(3):631-639. PubMed ID: 29145657 [TBL] [Abstract][Full Text] [Related]
15. Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. Marotta V; Zatelli MC; Sciammarella C; Ambrosio MR; Bondanelli M; Colao A; Faggiano A Endocr Relat Cancer; 2018 Jan; 25(1):R11-R29. PubMed ID: 29066503 [TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers. Herrera-Martínez AD; Hofland LJ; Gálvez Moreno MA; Castaño JP; de Herder WW; Feelders RA Endocr Relat Cancer; 2019 Mar; 26(3):R157-R179. PubMed ID: 30615596 [TBL] [Abstract][Full Text] [Related]
17. The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia. Bech PR; Martin NM; Ramachandran R; Bloom SR Ann Clin Biochem; 2014 Jan; 51(Pt 1):8-21. PubMed ID: 23939195 [TBL] [Abstract][Full Text] [Related]
18. Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy. Filosso PL; Öberg K; Malczewska A; Lewczuk A; Roffinella M; Aslanian H; Bodei L Eur J Cardiothorac Surg; 2020 Jun; 57(6):1195-1202. PubMed ID: 32047924 [TBL] [Abstract][Full Text] [Related]
19. Non-invasive screening for neuroendocrine tumors-Biogenic amines as neoplasm biomarkers and the potential improvement of "gold standards". Miękus N; Bączek T J Pharm Biomed Anal; 2016 Oct; 130():194-201. PubMed ID: 27344936 [TBL] [Abstract][Full Text] [Related]
20. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive. Pavel M; Jann H; Prasad V; Drozdov I; Modlin IM; Kidd M Neuroendocrinology; 2017; 104(2):170-182. PubMed ID: 27078712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]